Revolution Medicines, Inc. (42Z)
FSX
Real-time Data
06:00 AM
Day's Range
177.0552 wk Range
39.40Overview - 42Z - Revolution Medicines, Inc.
Key Statistics
Valuation
Enterprise Value
29.07B
P/E (Trailing)
‪-29.47‬
P/E (Forward)
‪-61.63‬
PEG Ratio
‪-0.22‬
Price / Book
‪15.79‬
EV / EBITDA
‪-20.50‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-30.12%‬
Return on Equity
‪-79.08%‬
Ownership
Shares Outstanding
214.24M
Float
184.49M
Held by Insiders
‪1.85%‬
Held by Institutions
‪101.00%‬
Price stats
Beta
‪1.40‬
50-Day Avg
‪173.19‬
200-Day Avg
‪123.92‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 42Z - Revolution Medicines, Inc.
Peers - 42Z - Revolution Medicines, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 49BAFSXBeOne Medicines Ltd. American Depositary Shares35.06BMarket Cap+9.68%52-week change63.27P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - 42Z - Revolution Medicines, Inc.
About
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing targeted therapies for RAS-addicted cancers. The company applies proprietary drug discovery capabilities to create small-molecule medicines designed to act on challenging RAS pathway targets, a central driver in many…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
